News | April 25, 2023
Boehringer Ingelheim inaugurates largest European development centre for biotechnology
New high-tech facility in Biberach offers attractive workplaces for more than 500 scientists
New high-tech facility in Biberach offers attractive workplaces for more than 500 scientists
SVB Financial Group and its subsidiaries were involved in over $1.4 billion in total venture financing raised from 2010 to 2022 for drug development
This order is subject to initial advance payment as per the agreed terms of the contract and this order will be executed within 6 to 8 months.
The company has reported total income of Rs.129.14 crores during the period ended December 31, 2022 as compared to Rs.157.54 crores during the period ended December 31, 2021.
The company is in the process of appointing the new Chief Financial Officer shortly and in the interim, Komal Gupta will continue as CFO
Zidavi is recommended by the Infectious Disease Society of America
This clearance allows the company to initiate a clinical trial for patients with an ileal pouch-anal anastomosis
This donation will allow the continuation of the cycle of vaccination for children foreseen within the national immunization program carried out by the Ministry of Public Health of Cuba
There have been reports from Uzbekistan concerning contaminated cough syrup Dok1 Max made by Indian company Marion Biotech, Noida, Uttar Pradesh
The company continue to develop this program for the WHO markets, thereby providing coverage and protection for more infants globally in time to come
Subscribe To Our Newsletter & Stay Updated
